Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
on behalf of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
Producción científica: Contribución a una revista › Artículo de revisión › revisión exhaustiva
327Citas
(Scopus)
Huella
Profundice en los temas de investigación de 'Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer'. En conjunto forman una huella única.